Novo A/S

Novo A/S discloses dealings in Novonesis (Novozymes A/S) to Finanstilsynet DK. Between 24 January 2014 and 15 May 2017, the trades on record add up to 27 filings.

Every open-market trade on record is a sale: 11 sales. The totals do not cover 11 filings with an undisclosed amount. Since January 2017: no purchases and 11 sales on the market.

Most recently, on 15 May 2017, the filings show an open-market sale in Novonesis (Novozymes A/S). The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by Finanstilsynet DK. They describe what insiders did and are not a recommendation.